![]() |
市場調查報告書
商品編碼
2032986
臍帶血庫服務市場規模、佔有率、趨勢和預測:按組成部分、儲存服務、應用和地區分類,2026-2034 年Cord Blood Banking Services Market Size, Share, Trends and Forecast by Component, Storage Services, Application, and Region, 2026-2034 |
||||||
2025年全球臍帶血庫服務市場規模為22億美元。展望未來,IMARC Group預測,該市場將在2026年至2034年間以8.66%的複合年成長率成長,到2034年達到48億美元。目前,北美市場佔據主導地位,預計2025年市佔率將超過33.8%。市場成長的原因包括:人們對幹細胞療法的認知不斷提高、遺傳性疾病盛行率上升、再生醫學的進步、政府舉措以及私人臍帶血庫的日益普及。此外,保存技術的改進、醫療保健支出的成長、研究應用的拓展以及主要地區出生率的提高也是推動臍帶血庫服務市場佔有率擴張的重要因素。
臍帶血庫是指從臍帶和胎盤中收集並儲存救命幹細胞,以備將來使用的過程。此過程包括利用嬰兒臍帶血中所含的造血幹細胞,並將其分化為紅血球、白血球和血小板。與骨髓幹細胞採集相比,臍帶血庫操作更簡便、疼痛更少、風險更低,因此在癌症、血液疾病和免疫系統疾病的治療中具有重要意義。正因如此,臍帶血庫在醫院、研究機構和專科診所得到了廣泛應用。
工作時間延長、生活壓力增加以及吸煙和飲酒過度導致包括淋巴瘤和白血病在內的多種癌症發病率上升,而這些癌症正是推動市場發展的主要因素。此外,臍帶血庫服務在全球範圍內用於治療免疫不全症的需求日益成長。加之人們對臍帶血庫服務益處的認知不斷提高以及服務提供者的廣泛普及,這些因素共同促進了市場成長。同時,許多國家的政府正大力投資研發活動,以加速臍帶血幹細胞的臨床試驗。這導致全球骨髓疾病患者數量增加,對市場產生了正面影響。此外,在監管指南和法規的指導下,私營機構進行的臍帶血診斷篩檢日益增多,為產業投資者提供了極具吸引力的成長機會。最後,醫療保健產業的蓬勃發展也是推動市場成長的重要因素。
本報告分析了全球臍帶血庫服務市場各細分領域的關鍵趨勢,並對2026年至2034年進行了全球、區域和國家層面的預測。市場按組件、儲存服務和應用進行細分。
也調查了該行業的競爭格局,並介紹了主要公司的概況,例如 Alphacord LLC、Americord Registry LLC、ATCC、California Cryobank、Cordlife Group Limited、Cryo-Cell International Inc.、Global Cord Blood Corporation、LifeBank、LifeCell International Pvt. Ltd.、National Cord Blood Program. Ltd.。
The global cord blood banking services market size was valued at USD 2.2 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 4.8 Billion by 2034, exhibiting a CAGR of 8.66% during 2026-2034. North America currently dominates the market, holding a significant market share of over 33.8% in 2025. The market is growing due to rising awareness about stem cell therapies, increasing prevalence of genetic disorders, advancements in regenerative medicine, government initiatives, and growing adoption of private banking. Moreover, the improved storage technologies, rising healthcare expenditure, expanding research applications, and increasing childbirth rates in key regions are some of the other factors fueling the cord blood banking services market share.
Cord blood banking is a procedure of collecting and storing life-saving stem cells from the umbilical cord and placenta for future use. It uses hematopoietic stem cells that are present in the cord blood of the baby to develop it into red blood cells (RBCs), white blood cells (WBCs) and platelets. It aids in the treatment of cancer, blood diseases and immune system disorders as cord blood banking is less complicated, painful and risky for the donor compared to the collection of stem cells from bone marrow. As a result, it finds extensive applications in hospitals, research institutes, and specialty clinics.
The growing prevalence of different cancers, such as lymphoma and leukemia, due to longer working hours, stressful lives, and excessive smoking and alcohol consumption represents one of the key factors driving the market. Moreover, there is an increase in the utilization of cord blood banking services for the treatment of immunodeficiency disorders across the globe. This, coupled with the increasing awareness among individuals about the benefits and wide availability of cord blood banking service providers, is propelling the growth of the market. In addition, governments of several countries are extensively investing in research and development (R&D) activities to facilitate clinical trials of cord blood stem cells. In line with this, the growing number of patients with damaged bone marrow worldwide is positively influencing the market. Besides this, the rising diagnostic screening of cord blood in private centers as per guidelines and regulations of regulatory authorities is offering lucrative growth opportunities to industry investors. Additionally, the expanding healthcare industry is strengthening the growth of the market.
This report provides an analysis of the key trends in each segment of the global cord blood banking services market, along with forecasts at the global, regional, and country levels from 2026-2034. The market has been categorized based on component, storage services, and application.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alphacord LLC, Americord Registry LLC, ATCC, California Cryobank, Cordlife Group LImited, Cryo-Cell International Inc., Global Cord Blood Corporation, LifeBank, LifeCell International Pvt. Ltd., National Cord Blood Program, Norton Healthcare Inc., Perkinelmer Inc. and StemCyte India Therapeutics Pvt. Ltd.